Literature DB >> 33941087

Gene expression profiling of inflammatory cytokines in esophageal biopsies of different phenotypes of gastroesophageal reflux disease: a cross-sectional study.

Mónica R Zavala-Solares1, Gabriela Fonseca-Camarillo2, Miguel Valdovinos3, Julio Granados4, Guido Grajales-Figueroa5, Luis Zamora-Nava5, Nancy Aguilar-Olivos5, Luis R Valdovinos-García5, Jesús K Yamamoto-Furusho6.   

Abstract

BACKGROUND: The clinical endoscopic phenotypes of gastroesophageal reflux disease (GERD) are classified as Barrett's esophagus (BE), erosive esophagitis (EE) and non-erosive gastroesophageal reflux disease (NERD). NERD is subclassified as abnormal acid exposure (AAE) and normal acid exposure (NAE) based on pH monitoring study results. The aim of this study was to characterize genes involved in the pathophysiology and immune response of GERD.
METHODS: This is an observational and cross-sectional study. All patients with BE, EE, AAE, and NAE and a control group were subjected to superior endoscopy (with biopsies of esophageal mucosa). Relative mRNA quantification of cytokine and target genes was conducted by quantitative Polymerase Chain Reaction (RT-qPCR). Changes in the expression of genes associated with inflammation were assessed for each disease phenotype. Statistical analysis of differential gene expression was performed using the Mann-Whitney U non-parametric test. A p value < 0.05 was considered significant.
RESULTS: A total of 82 patients were included and were divided into the following groups: Group BE, 16 (19.51%); Group EE, 23 (28.04%); Group AAE, 13 (15.86%); NAE 13 (15.86%); and Control Group, 17 (20.73%). Compared with the control group, patients with BE exhibited increased IL-8 expression (p < 0.05) and increased levels of IL-10, MMP-3, and MMP-9. Patients with EE exhibited increased levels of IL-1B, IL-6 and IL-10 (p < 0.05), and patients with AAE exhibited increased expression of IL-1B, IL-6, IFN-γ and TNF-α (p < 0.05). AAE exhibited increased IL-1B and TNF-α expression compared with NAE (p < 0.05).
CONCLUSION: This study demonstrates the differential expression of mediators of inflammation in the esophageal mucosa of patients with different GERD endoscopic phenotypes. IL-1B and TNF-α could be useful to differentially diagnose AAE and NAE in the non-erosive phenotype using endoscopic biopsies.

Entities:  

Keywords:  Cytokine; Esophagitis; Gene; Non-Erosive Reflux Disease (NERD)

Year:  2021        PMID: 33941087     DOI: 10.1186/s12876-021-01707-7

Source DB:  PubMed          Journal:  BMC Gastroenterol        ISSN: 1471-230X            Impact factor:   3.067


  5 in total

1.  Mechanisms of Chinese Medicine in Gastroesophageal Reflux Disease Treatment: Data Mining and Systematic Pharmacology Study.

Authors:  Hao-Yu Chen; Qi Li; Ping-Ping Zhou; Tian-Xiao Yang; Shao-Wei Liu; Teng-Fei Zhang; Zhen Cui; Jing-Jing Lyu; Yan-Gang Wang
Journal:  Chin J Integr Med       Date:  2022-08-23       Impact factor: 2.626

2.  Network Pharmacology Analysis of Hewei Jiangni Granule for Gastroesophageal Reflux Disease and Experimental Verification of Its Anti-Neurogenic Inflammation Mechanism.

Authors:  Yuan Cheng; Fushun Kou; Xiaosi Zhang; Yi Dai; Lei Shi; Chune Xie; Xiaohong Li; Junxiang Li
Journal:  Drug Des Devel Ther       Date:  2022-05-05       Impact factor: 4.319

3.  Identification of Unique Transcriptomic Signatures and Hub Genes Through RNA Sequencing and Integrated WGCNA and PPI Network Analysis in Nonerosive Reflux Disease.

Authors:  Ye Zhao; Teng Ma; Duowu Zou
Journal:  J Inflamm Res       Date:  2021-11-23

4.  Local inflammatory response to gastroesophageal reflux: Association of gene expression of inflammatory cytokines with esophageal multichannel intraluminal impedance-pH data.

Authors:  Sergey Morozov; Tatyana Sentsova
Journal:  World J Clin Cases       Date:  2022-09-16       Impact factor: 1.534

5.  Herbal Medicine Hewei Jiangni Decoction Is Noninferior to Oral Omeprazole for the Treatment of Nonerosive Gastroesophageal Reflux Disease: A Randomized, Double-Blind, and Double-Dummy Controlled Trail.

Authors:  Feng Li; Yali Yuan; Di Wu; Junxiang Li; Haixiao Han; Xiaohong Li; Liming Hu; Runhua Chen; Yupu Yao; Yao Jiao; Huihui Chen; Tangyou Mao; Chune Xie
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-22       Impact factor: 2.650

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.